# Case Report: A pediatric case of the clear-cell variant of mucoepidermoid carcinoma in the palate harboring MAML2 gene rearrangement

**Authors:** Hengkun Wang, Xiaoya Wang

PMC · DOI: 10.3389/fped.2025.1600823 · Frontiers in Pediatrics · 2025-07-03

## TL;DR

A 13-year-old girl was diagnosed with a rare type of cancer in her palate, which was successfully treated with surgery and showed no recurrence after one year.

## Contribution

This paper reports a rare pediatric case of clear-cell mucoepidermoid carcinoma with MAML2 gene rearrangement in the palate.

## Key findings

- The tumor was diagnosed as a medium-grade clear-cell variant of mucoepidermoid carcinoma with pT1N0M0 staging.
- MAML2 gene rearrangement was confirmed using fluorescence in situ hybridization.
- Complete surgical resection led to a favorable outcome with no recurrence after one year.

## Abstract

The clear-cell variant of mucoepidermoid carcinoma (MEC) is a rare subtype, with pediatric cases being extremely rare. A 13-year-old girl presented with a lesion on the right palate, which had been noted for 3 months. The patient reported pain, rupture, and bleeding of the tumor for nearly a month. Computed tomography scans revealed a quasi-circular soft tissue mass on the right hard palate. Microscopically, the tumor cells showed predominant clear cells and scattered mucous cells. The tumor cells were positive for cytokeratin (CK), CK7, CK5/6, epithelial membrane antigen, P63, and P40. A rearrangement of mastermind-like transcriptional coactivator 2 (MAML2) (11q21) gene was identified in the tumor cells by fluorescence in situ hybridization. The histological features supported a diagnosis of clear-cell variant of MEC, medium grade, with a tumor stage of pT1N0M0. The patient underwent a complete excision of the palatal mass followed by superficial bone removal. After surgery, the patient recovered well and was recurrence-free at the 1-year follow-up. Based on repeated pathological evaluations, we report this rare pediatric case of a clear-cell variant of MEC of the palate. Only surgical resection resulted in a favorable outcome.

## Linked entities

- **Genes:** MAML2 (mastermind like transcriptional coactivator 2) [NCBI Gene 84441]
- **Proteins:** krt12.4.S (Keratin 12, gene 4 S homeolog), KRT7 (keratin 7), ck56 (hypothetical protein), RPE65 (retinoid isomerohydrolase RPE65), IL9 (interleukin 9)
- **Diseases:** mucoepidermoid carcinoma (MONDO:0003036)

## Full-text entities

- **Genes:** KRT7 (keratin 7) [NCBI Gene 3855] {aka CK7, K2C7, K7, SCL}, MAML2 (mastermind like transcriptional coactivator 2) [NCBI Gene 84441] {aka MAM-3, MAM2, MAM3, MLL-MAML2}, TP63 (tumor protein p63) [NCBI Gene 8626] {aka AIS, B(p51A), B(p51B), EEC3, KET, LMS}, CMPK1 (cytidine/uridine monophosphate kinase 1) [NCBI Gene 51727] {aka CK, CMK, CMPK, UMK, UMP-CMPK, UMPK}
- **Diseases:** pain (MESH:D010146), rupture (MESH:D012421), tumor (MESH:D009369), bleeding (MESH:D006470), MEC (MESH:D018277)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12267255/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12267255/full.md

## References

17 references — full list in the complete paper: https://tomesphere.com/paper/PMC12267255/full.md

---
Source: https://tomesphere.com/paper/PMC12267255